=

«

»

Pharma market booms in China

London, UK: China will represent the greatest “emerging market” opportunity in the global pharmaceutical temperature controlled supply chain in five years time, according to a new report.

Operating a Global Temperature-Controlled Supply Chain, a Cold Chain IQ special report, says that the number of temperature sensitive drugs is increasing in the pharmaceutical pipeline.

Ensuring the safe storage and distribution of temperature sensitive materials remains a constant challenge for the pharmaceutical industry.

This report looks at the technologies and strategies the industry is employing to leverage partnerships and streamline processes in their supply chains of temperature sensitive products.

The report reveals that 96% of respondents consider cold chain or temperature control a core competency of their logistics provider.

Another key finding was that 71% of professionals in pharmaceutical distribution planned to increase investment over the next 10 years.  And 63% said finding cost-effective solutions / products is their key challenge in the storage and distribution of controlled room temperature and ambient products.

“A global reach and local market expertise is essential for ensuring seamless distribution of temperature sensitive pharmaceuticals on a global level,” says the report. “Manufacturers and distributors alike must address global and local challenges together to ensure a temperature assured supply chain. Investment in new technologies and infrastructure alongside robust partnerships can reduce cost, maintain quality and increase efficiency.